Patents by Inventor MONIC J. STUART

MONIC J. STUART has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms
    Publication number: 20230183704
    Abstract: Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have Essential Thrombocythemia (ET). Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having ET.
    Type: Application
    Filed: July 13, 2022
    Publication date: June 15, 2023
    Inventors: Monic J. Stuart, Stephen Kelsey
  • Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms
    Publication number: 20200102564
    Abstract: Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have Essential Thrombocythemia (ET). Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having ET.
    Type: Application
    Filed: September 25, 2018
    Publication date: April 2, 2020
    Inventors: Monic J. Stuart, Stephen Kelsey
  • USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
    Publication number: 20170051287
    Abstract: Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have Essential Thrombocythemia (ET). Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having ET.
    Type: Application
    Filed: May 25, 2016
    Publication date: February 23, 2017
    Inventors: MONIC J. STUART, STEPHEN KELSEY
  • Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
    Patent number: 9375485
    Abstract: Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have Essential Thrombocythemia (ET). Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having ET.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: June 28, 2016
    Assignee: Geron Corporation
    Inventors: Monic J. Stuart, Stephen Kelsey
  • Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms
    Publication number: 20150342982
    Abstract: Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have myeloproliferative disorders, such as Essential Thrombocythemia (ET). Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having myeloproliferative disorders, such as ET.
    Type: Application
    Filed: November 15, 2013
    Publication date: December 3, 2015
    Inventors: Monic J. STUART, Stephen KELSEY
  • USE OF TELOMERASE INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS
    Publication number: 20140163090
    Abstract: Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have Essential Thrombocythemia (ET). Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges in the blood of individuals diagnosed with or suspected of having ET.
    Type: Application
    Filed: March 15, 2013
    Publication date: June 12, 2014
    Inventors: MONIC J. STUART, STEPHEN KELSEY